What are the clinical and laboratory criteria for diagnosing adrenal crisis in patients with known or suspected adrenal insufficiency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Criteria for Adrenal Crisis

Adrenal crisis is diagnosed clinically by the presence of hypotension or hypovolemic shock PLUS at least one of the following: nausea/vomiting, severe fatigue, fever, or impaired consciousness (including lethargy, confusion, somnolence, collapse, delirium, coma, or seizures). 1

Core Diagnostic Criteria

The diagnosis is fundamentally clinical and does not require laboratory confirmation before treatment. According to the 2024 European Society of Endocrinology/Endocrine Society joint guideline, you need:

Required Finding:

  • Hypotension or hypovolemic shock

PLUS at least ONE of:

  • Nausea or vomiting
  • Severe fatigue
  • Fever
  • Impaired consciousness (lethargy, confusion, somnolence, collapse, delirium, coma, seizures)

1

Key Clinical Characteristics

Shock out of proportion to the trigger is the hallmark presentation. The shock is typically resistant to inotropes and fluid resuscitation until parenteral glucocorticoids are administered. 1 This resistance to standard resuscitation measures should immediately raise suspicion for adrenal crisis.

Laboratory Findings (Supportive but NOT Required for Diagnosis)

While laboratory abnormalities support the diagnosis, treatment must never be delayed for laboratory confirmation. Common findings include:

  • Hyponatremia (77% of cases) 2
  • Hyperkalemia (in primary adrenal insufficiency)
  • Hypoglycemia
  • Elevated plasma renin activity

The 2016 Endocrine Society guideline emphasizes that treatment takes precedence over diagnostic confirmation. 3

Critical Clinical Context

High-Risk Populations:

  • Patients with known adrenal insufficiency
  • Current or recent glucocorticoid users (any formulation: oral, inhaled, topical, intra-articular) 1
  • Patients immediately following glucocorticoid cessation
  • Older adults (>65 years)
  • Adolescents transitioning from pediatric to adult care
  • History of previous adrenal crises 1

Common Precipitating Factors:

  • Infections (gastrointestinal, genitourinary, respiratory, sepsis) - most common trigger
  • Vomiting/diarrhea (65% of cases) 2
  • Physical trauma or surgery
  • Abrupt glucocorticoid withdrawal
  • Emotional stress (29% of cases) 2
  • Initiation of CYP3A4 inducers (carbamazepine, phenytoin, rifampicin, etc.) 1

Critical Pitfalls to Avoid

  1. Do NOT wait for laboratory confirmation - The diagnosis is clinical and treatment must be immediate 1, 3

  2. Do NOT assume only oral glucocorticoid users are at risk - Adrenal crisis occurs with inhaled, topical, and intra-articular formulations due to systemic absorption 1

  3. Do NOT overlook the post-cessation period - Adrenal crisis can occur weeks to months after stopping glucocorticoids 1

  4. Do NOT dismiss vague symptoms - The presentation is often nonspecific with fatigue (96% of cases) and gastrointestinal symptoms (85%) being predominant 2

  5. Do NOT rely on hyperpigmentation - This is absent in secondary adrenal insufficiency and acute-onset primary insufficiency 4

Immediate Management Protocol

When adrenal crisis is suspected based on the above criteria:

  1. Immediate parenteral hydrocortisone 100 mg IV or IM (50 mg/m² in children) 1, 3
  2. Rapid volume resuscitation with 0.9% saline (1000 mL in first hour for adults) 3
  3. Followed by 200 mg hydrocortisone/24 hours (continuous IV or divided q6h) 3

Treatment should be initiated even if the diagnosis is eventually ruled out - the short-term administration of parenteral glucocorticoids at these doses is safe. 1 The risk of withholding treatment far exceeds any risk from empiric therapy.

Distinguishing Features by Type

Primary adrenal insufficiency typically presents with:

  • Hyperkalemia
  • Hyperpigmentation (if chronic)
  • Elevated ACTH
  • Elevated plasma renin activity

Secondary adrenal insufficiency presents with:

  • NO hyperkalemia (mineralocorticoid function preserved)
  • NO hyperpigmentation
  • Low or inappropriately normal ACTH

However, in acute crisis, these distinctions are less important than immediate recognition and treatment. 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.